Literature DB >> 25862280

Multilocus sequence typing of Australian Streptococcus suis type 2 by MALDI-TOF mass spectrometry analysis of PCR amplicons.

Mitchell D Groves1, David Jordan2, Toni A Chapman3, Rafat Al Jassim4.   

Abstract

Streptococcus suis serotype 2 is a ubiquitous pathogen of swine and is known to cause severe disease in humans. Multilocus sequence typing (MLST) is ideal for characterising this organism because it permits isolates to be compared on a national and international scale. A novel approach to MLST using matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MS-MLST) provides a more rapid alternative to dideoxy sequencing. This study used MS-MLST to define the multilocus sequence types (STs) present among a collection of Australian S. suis type 2, and thus, delivered a basis for comparison of Australian isolates with international strains already well characterised for virulence attributes. A collection of 45 isolates recovered from infected humans (n=3) and diseased pigs (n=42) was genotyped using MS-MLST and conventional MLST. Both methods were 100% concordant in their classification of sequence types (STs), although MS-MLST permitted much quicker analysis of sequence data. The collection contained ST25 (n=31), ST1 (n=10), ST28 (n=3) and ST369 (n=1). These results are consistent with the population structure of S. suis type 2 observed in diseased pigs and humans in Canada and the United Kingdom. MS-MLST may have utility for studying the population structure and epidemiology of S. suis in countries where the diversity of S. suis is greater and human disease is more common. Crown
Copyright © 2015. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MLST; Pigs; Streptococcus suis; Zoonosis

Mesh:

Year:  2015        PMID: 25862280     DOI: 10.1016/j.vetmic.2015.03.006

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis.

Authors:  Mariela Segura; Virginia Aragon; Susan L Brockmeier; Connie Gebhart; Astrid de Greeff; Anusak Kerdsin; Mark A O'Dea; Masatoshi Okura; Mariette Saléry; Constance Schultsz; Peter Valentin-Weigand; Lucy A Weinert; Jerry M Wells; Marcelo Gottschalk
Journal:  Pathogens       Date:  2020-05-14

2.  In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928.

Authors:  Fei Zhao; Na Yang; Xiumin Wang; Ruoyu Mao; Ya Hao; Zhanzhan Li; Xiao Wang; Da Teng; Huan Fan; Jianhua Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-02-26       Impact factor: 5.293

3.  MALDI-TOF Mass Spectrometry for Multilocus Sequence Typing of Escherichia coli Reveals Diversity among Isolates Carrying blaCMY₋₂-Like Genes.

Authors:  Kaitlin A Tagg; Andrew N Ginn; Sally R Partridge; Jonathan R Iredell
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

Review 4.  Tools for Molecular Epidemiology of Streptococcus suis.

Authors:  Rujirat Hatrongjit; Nahuel Fittipaldi; Marcelo Gottschalk; Anusak Kerdsin
Journal:  Pathogens       Date:  2020-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.